Literature DB >> 28808055

Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).

Shusaku Shibutani1, Hana Okazaki2, Hiroyuki Iwata3.   

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of protein synthesis and potential target for modifying cellular metabolism in various conditions, including cancer and aging. mTORC1 activity is tightly regulated by the availability of extracellular amino acids, and previous studies have revealed that amino acids in the extracellular fluid are transported to the lysosomal lumen. There, amino acids induce recruitment of cytoplasmic mTORC1 to the lysosome by the Rag GTPases, followed by mTORC1 activation by the small GTPase Ras homolog enriched in brain (Rheb). However, how the extracellular amino acids reach the lysosomal lumen and activate mTORC1 remains unclear. Here, we show that amino acid uptake by dynamin-dependent endocytosis plays a critical role in mTORC1 activation. We found that mTORC1 is inactivated when endocytosis is inhibited by overexpression of a dominant-negative form of dynamin 2 or by pharmacological inhibition of dynamin or clathrin. Consistently, the recruitment of mTORC1 to the lysosome was suppressed by the dynamin inhibition. The activity and lysosomal recruitment of mTORC1 were rescued by increasing intracellular amino acids via cycloheximide exposure or by Rag overexpression, indicating that amino acid deprivation is the main cause of mTORC1 inactivation via the dynamin inhibition. We further show that endocytosis inhibition does not induce autophagy even though mTORC1 inactivation is known to strongly induce autophagy. These findings open new perspectives for the use of endocytosis inhibitors as potential agents that can effectively inhibit nutrient utilization and shut down the upstream signals that activate mTORC1.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  amino acid; autophagy; dynamin; endocytosis; mTORC1; mammalian target of rapamycin (mTOR); mechanistic target of rapamycin (mTOR)

Mesh:

Substances:

Year:  2017        PMID: 28808055      PMCID: PMC5672031          DOI: 10.1074/jbc.M117.776443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  PET imaging of prostate cancer with 11C-acetate.

Authors:  Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

2.  Dynasore, a cell-permeable inhibitor of dynamin.

Authors:  Eric Macia; Marcelo Ehrlich; Ramiro Massol; Emmanuel Boucrot; Christian Brunner; Tomas Kirchhausen
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

3.  Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis.

Authors:  Tom Kirchhausen; Eric Macia; Henry E Pelish
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

4.  Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.

Authors:  K Hara; K Yonezawa; Q P Weng; M T Kozlowski; C Belham; J Avruch
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 5.  Promoting health and longevity through diet: from model organisms to humans.

Authors:  Luigi Fontana; Linda Partridge
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

6.  Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion.

Authors:  Jing Zhou; Shi-Hao Tan; Valérie Nicolas; Chantal Bauvy; Nai-Di Yang; Jianbin Zhang; Yuan Xue; Patrice Codogno; Han-Ming Shen
Journal:  Cell Res       Date:  2013-01-22       Impact factor: 25.617

Review 7.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

8.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

Review 9.  Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.

Authors:  Dudley W Lamming
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

Review 10.  Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot.

Authors:  Deborah C I Goberdhan; Clive Wilson; Adrian L Harris
Journal:  Cell Metab       Date:  2016-04-12       Impact factor: 27.287

View more
  8 in total

Review 1.  Deregulation of autophagy and vesicle trafficking in Parkinson's disease.

Authors:  Patricia Sheehan; Zhenyu Yue
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

2.  TXNIP inhibits the progression of osteosarcoma through DDIT4-mediated mTORC1 suppression.

Authors:  Yuhao Yuan; Qing Liu; Ziyi Wu; Wei Zhong; Zili Lin; Wei Luo
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

Review 3.  High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.

Authors:  Shunling Yuan; Zhaoping Liu; Zhenru Xu; Jing Liu; Ji Zhang
Journal:  J Hematol Oncol       Date:  2020-07-13       Impact factor: 17.388

Review 4.  Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson's Disease.

Authors:  Giulia Lamonaca; Mattia Volta
Journal:  Cells       Date:  2020-04-30       Impact factor: 6.600

5.  Up-regulating autophagy by targeting the mTOR-4EBP1 pathway: a possible mechanism for improving cardiac function in mice with experimental dilated cardiomyopathy.

Authors:  Bo Jin; Haiming Shi; Jun Zhu; Bangwei Wu; Quzhen Geshang
Journal:  BMC Cardiovasc Disord       Date:  2020-02-04       Impact factor: 2.298

6.  Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells.

Authors:  Cedric S Tremblay; Sung Kai Chiu; Jesslyn Saw; Hannah McCalmont; Veronique Litalien; Jacqueline Boyle; Stefan E Sonderegger; Ngoc Chau; Kathryn Evans; Loretta Cerruti; Jessica M Salmon; Adam McCluskey; Richard B Lock; Phillip J Robinson; Stephen M Jane; David J Curtis
Journal:  Nat Commun       Date:  2020-12-04       Impact factor: 14.919

7.  Dynamic interactions and intracellular fate of label-free, thin graphene oxide sheets within mammalian cells: role of lateral sheet size.

Authors:  Yingxian Chen; Jack Rivers-Auty; Livia Elena Crică; Katie Barr; Vinicio Rosano; Adrián Esteban Arranz; Thomas Loret; David Spiller; Cyrill Bussy; Kostas Kostarelos; Sandra Vranic
Journal:  Nanoscale Adv       Date:  2021-06-15

Review 8.  Macropinocytosis, mTORC1 and cellular growth control.

Authors:  Sei Yoshida; Regina Pacitto; Ken Inoki; Joel Swanson
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.